SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019179
Filing Date
2016-05-12
Accepted
2016-05-12 08:57:22
Documents
58
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dmtx-10q_20160331.htm 10-Q 1630978
2 EX-31.1 dmtx-ex311_345.htm EX-31.1 17135
3 EX-31.2 dmtx-ex312_344.htm EX-31.2 17139
4 EX-32.1 dmtx-ex321_343.htm EX-32.1 13041
5 GRAPHIC gm1y45bjcjdy000001.jpg GRAPHIC 39142
  Complete submission text file 0001564590-16-019179.txt   4870538

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dmtx-20160331.xml EX-101.INS 864279
7 XBRL TAXONOMY EXTENSION SCHEMA dmtx-20160331.xsd EX-101.SCH 37221
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmtx-20160331_cal.xml EX-101.CAL 37682
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmtx-20160331_def.xml EX-101.DEF 104745
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmtx-20160331_lab.xml EX-101.LAB 296526
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmtx-20160331_pre.xml EX-101.PRE 224669
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37601 | Film No.: 161641771
SIC: 2836 Biological Products, (No Diagnostic Substances)